US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
ETF
イギリス
LSE
United Utilities Water Finance Plc (FO43) 銘柄情報

United Utilities Water Finance Plc (FO43)

0.00

0.00

( 0.00% )

更新日時： -

United Utilities Water Finance Plc (FO43) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

-

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

£ 0

発行済株式数

50,000

配当利回り

PER

-

1 株当たり利益 (EPS)

1.06

歳入

50k

純利益

53k

United Utilities Water Finance PLC provides long term finance for United Utilities Water Limited. The company was incorporated in 2014 and is based in Warrington, United Kingdom. United Utilities Water Finance PLC operates as a subsidiary of United Utilities Water Limited. United Utilities Water Finance PLC provides long term finance for United Utilities Water Limited. The company was incorporated in 2014 and is based in Warrington, United Kingdom. United Utilities Water Finance PLC operates as a subsidiary of United Utilities Water Limited.

セクター

-

業界

-

本社

Warrington, United Kingdom

設立

2026

United Utilities Water Finance Plc is listed in the sector of the ロンドン証券取引所 with ticker FO43. The last closing price for United Utilities Water F... was -. Over the last year, United Utilities Water F... shares have traded in a share price range of £ 0.00 to £ 0.00.

United Utilities Water F... currently has 50,000 shares in issue.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ADTXAditxt Inc	US$ 0.0218 (118.00%)	667.41M
EHGOEshallgo Inc	US$ 3.27 (81.67%)	14.88M
SAGTSagtec Global Ltd	US$ 1.7403 (75.79%)	22.04M
TNONTenon Medical Inc	US$ 0.5327 (52.20%)	24.62M
APGEApogee Therapeutics Inc	US$ 137.00 (51.58%)	69.58k
AIXIXIAO-I Corporation	US$ 2.78 (-55.59%)	174.15k
LICNLichen International Ltd	US$ 1.70 (-21.66%)	3.7k
NIPGNIP Group Inc	US$ 0.2251 (-19.89%)	958.38k
SNBRSleep Number Corporation	US$ 0.1711 (-17.42%)	763.02k
FFIVF5 Inc	US$ 318.6615 (-17.34%)	12
ADTXAditxt Inc	US$ 0.0218 (118.00%)	667.6M
GDCGD Culture Group Ltd	US$ 0.0244 (34.81%)	532.13M
INLFINLIF Limited	US$ 0.1858 (18.65%)	86.1M
PAVSParanovus Entertainment Technology Ltd	US$ 0.1668 (11.95%)	38.23M
CDTCDT Equity Inc	US$ 1.5197 (48.99%)	32.22M

iHub News

iHub News 3分前

Jefferies Lowers Tesla Target and Highlights Potential SpaceX Tracking Stock RiskJune 22, 2026 6:41 AM
IH Market News

iHub News

iHub News 3分前

Jefferies Lowers Tesla Target and Highlights Potential SpaceX Tracking Stock RiskJune 22, 2026 6:41 AM
IH Market News

US Market News

US Market News 4分前

Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)June 22, 2026 6:45 AM
Business Wire Tulisokibart is the first anti-TL1A monoclonal an

CA Market News

CA Market News 4分前

Radisson Continues to Extend Scope of Gold Mineralization at the O'Brien Gold Project with Latest Drill ResultsJune 22, 2026 6:30 AM
Newsfile

CA Market News

CA Market News 4分前

TELUS Numérique et ElevenLabs s'associent pour développer l'IA vocale aux côtés des équipes de service à la clientèle de première ligneJune 22, 2026 6:45 AM
PR Newswire (Canada) Ce partenariat intègre ElevenAgents à l'expérience client de

US Market News

US Market News 4分前

TELUS Digital and ElevenLabs Partner to Scale Voice AI Alongside Frontline Customer Care TeamsJune 22, 2026 6:45 AM
PR Newswire (US) The partnership brings ElevenAgents to enterprise customer experience, with TELUS Digital
providing

US Market News

US Market News 4分前

AECOM secures nine lots on UK Government Commercial Agency CPS2 FrameworkJune 22, 2026 6:55 AM
Business Wire The multi-billion dollar framework will see AECOM support the UK public sector in an expanded role across its estate in markets including social infrastructure, nuclear

iHub News

iHub News 4分前

SpaceX Shares Slide in Premarket Trading as Valuation Concerns IntensifyJune 22, 2026 6:50 AM
IH Market News

Golden Cross

Golden Cross 6分前

$GDC oversold play

jimmybob

jimmybob 6分前

$MRNA PT raised to $24 from $21 at Leerink - keeps Underperform rating

seventhcircle

seventhcircle 7分前

$TKOI held over .02 let’s see if this is bottom

highlandernew

highlandernew 7分前

🔴🔴World's LARGEST Movie Co. under $700M m/cap RIGHT?:

Source?: https://finance.yahoo.com/quote/AMC/key-statistics/

https://investorshub.advfn.com/uimage/uploads/2024/11/22/ftwvhAMC_I_DID_THAT_NOT_SORRY.png

Real AMC shares are Apex propert

falkus951

falkus951 9分前

$ADTX..uneblievable!!!.. see the pre-market action

Chart
https://schrts.co/khvHEcMK
Share Structure
https://www.otcmarkets.com/stock/ADTX/security
Social Media
https://stocktwits.com/symbol/ADTX
https://x.com/search?q=%24ADTX&src=recent_search

falkus951

falkus951 9分前

$ADTX..uneblievable!!!.. see the pre-market action

Chart
https://schrts.co/khvHEcMK
Share Structure
https://www.otcmarkets.com/stock/ADTX/security
Social Media
https://stocktwits.com/symbol/ADTX
https://x.com/search?q=%24ADTX&src=recent_search

sab63090

sab63090 13分前

novicetrader:

Yes, it can re-occur! The virus remains in the body and as we age & our immunity declines, so it can return multiple times.

The recommendation for my wife from our pharmacist was to get the new shingles shots (2 shots....2-6 months apart)...

jimmybob

jimmybob 15分前

👀👀👀FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says

$RGNX $REPL $IBB

https://www.wsj.com/tech/biotech/fda-will-reverse-rejection-of-third-rare-disease-drug-regenxbio-says-d8fff1fc?mod=hp_lead_pos6

US Market News

US Market News 18分前

Ennis, Inc. Reports Results for the Quarter Ended May 31, 2026 and Declares Quarterly DividendJune 22, 2026 6:30 AM
Business Wire Ennis, Inc. (the “Company”), (NYSE: EBF), today reported financial results for the quarter ended May 31, 2026. Highlights include:

United Utilities Water F...

Entheon Biomedical (ID)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。